(RTTNews) - Clearmind Medicine Inc. (CMND) Tuesday said it has submitted an additional patent application with the United States Patent and Trademark Office, as part of its ongoing collaborations with ...
Vancouver, Canada, July 16, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development ...
Metabolic syndrome increases a person's risk for diabetes, heart disease, and stroke, and includes conditions such as obesity, high blood pressure and high blood sugar. In a recent mouse-model study, ...
Metabolic syndrome increases a person's risk for diabetes, heart disease, and stroke, and includes conditions such as obesity, high blood pressure and high blood sugar. In a recent mouse-model study, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback